Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years

Stroke

Volumn 36, Issue 7, 2005, Pages 1405-1409

  Lalouschek, Wolfgang ^a,d,e   Schillinger, Martin ^b,d   Hsieh, Kety ^c,d   Endler, Georg ^c,d   Tentschert, Susanne ^a,d   Lang, Wilfried ^a,d,e   Cheng, Suzanne ^d,f   Mannhalter, Christine ^c,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department of Angiology ^*  (Austria)

^c Clin Inst Med Chem Lab D   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^f ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

Factor V; Mutation; Prothrombin; Stroke

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTERY THROMBOSIS; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN GENE; RISK FACTOR; SMOKING; TRANSIENT ISCHEMIC ATTACK;

ALLELES; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; ODDS RATIO; POLYMERASE CHAIN REACTION; PROTHROMBIN; RISK; RISK FACTORS; SEX FACTORS; SMOKING; THROMBOSIS;

EID: 22044438499     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000170635.45745.b8     Document Type: Article

References (28)

1. Endler G, Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta. 2003; 330:31-55.
2. Juul K, Tybjaerg Hansen A, Steffensen R, Kofoed S, Jensen G, Nordestgaard BG. Factor V Leiden: the Copenhagen City Heart Study and 2 meta-analyses. Blood. 2002;100:3-10.
3. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G2021OA, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J. 2003;146:948-957.
4. Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen Makelin R, Hamalainen L, Palomaki H, Kaste M. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost. 1995;73:558-560.
5. Landi G, Cella E, Maninelli I, Tagliabue L, Mannucci PM, Zerbi D. Arg506Gln factor V mutation and cerebral ischemia in the young. Stroke. 1996;27:1697-1698.
6. Bentolila S, Ripoll L, Drouet L, Mazoyer E, Woimant F. Thrombophilia due to 20210 G-A prothrombin polymorphism and cerebral ischemia in the young. Stroke. 1997;28:1846-1847.
7. Maninelli I, Franchi F, Akwan S, Bettini P, Merati G, Mannucci PM. The transition G to A at position 20210 in the 3′ untranslated region of the prothrombin gene is not associated with cerebral ischemia. Blood. 1997; 90:3806.
8. DeStefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari F, Servidei S, Tonali PA, Leone G. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood. 1998;91:3562-3565.
9. Longstreth WT, Jr., Rosendaal FR, Siscovick DS, Vos HL, Schwartz SM, Psaty BM, Raghunathan TE, Koepsell TD, Reitsma PH. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke. 1998;29: 577-580.
10. Nabavi DG, Junker R, Wolff E, Ludemann P, Doherty C, Evers S, Droste DW, Kessler C, Assmann G, Ringelstein EB. Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients. J Neurol. 1998;245:653-658.
11. Margaglione M, D'AG, Giuliani N, Brancaccio V, De LD, Grandone E, De SV, Tonali PA, Di MG. Inherited prothrombotic conditions and premature ischemic stroke-sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol. 1999;19:1751-1756.
12. Voetsch B, Damasceno BP, Camargo EC, Massaro A, Bacheschi LA, Scaff M, Annichino Bizzacchi JM, Arruda VR. Inherited thrombophilia as a risk factor for the development of ischemic stroke in young adults. Thromb Haemost. 2000;83:229-233.
13. Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, Kuczynska Zardzewialy A, Szelagowska D, Windyga J, Schroder W, Herrmann FH, Jedrzejowska H. Factor V Leiden, pro-thrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost. 2001;7:346-350.
14. Madonna P, de Stefano V, Coppola A, Cirillo F, Cerbone AM, Orefice G, Di Minno G. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke. 2002;33:51-56.
15. Aznar J, Mira Y, Vaya A, Corella D, Ferrando F, Villa P, Estelles A. Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke. Thromb Haemost. 2004;91: 1031-1034.
16. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT, Jr., Raghunathan TE, Koepsell TD, Reitsma PH. Factor V Leiden (resistance to activated protein c) increases the risk of myocardial infarction in young women. Blood. 1997;89:2817-2821.
17. Tanis BC, Bloemenkamp DG, van den Bosch MA, Kemmeren JM, Algra A, van de Graaf Y, Rosendaal FR. Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction. Br J Haematol. 2003;122:471-478.
18. Vienna Stroke Registry. Vienna Stroke Study Group. The Vienna Stroke Registry-objectives and methodology. Wien Klin Wochenschr. 2001; 113:141-147.
19. Lalouschek W, Lang W, Mullner M. Current strategies of secondary prevention after a cerebrovascular event: the Vienna Stroke Registry. Stroke. 2001;32:2860-2866.
20. Lukas A, Kumbein F, Mayer B, Oberbauer R, Temml C, Lukas A. Body mass index is the main risk factor for arterial hypertension in young subjects without major comorbidity. Eur J Clin Invest. 2003:223-230.
21. Endler G, Kyrle P, Eichinger S, Exner M, Mannhalter C. Multiplexed mutagenically separated PCR: simultaneous single-tube detection of the factor V R506Q (G1691A), the prothrombin G20210A, and the methylenetetrahydrofolate reductase A223V (C677T) variants. Clin Chem. 2001;47:333-335.
22. Cheng S, Grow MA, Pallaud C, Klitz W, Erlich HA, Visvikis S, Chen JJ, Pullinger CR, Malloy MJ, Siest G, Kane JP. A multilocus genotyping assay for candidate markers of cardiovascular disease risk. Genome Res. 1999;9:936-949.
23. Henkens C, Bom V, Seinen A, van der Meer J. Sensitivity to activated protein c: influence of oral contraceptives and sex. Thromb Haemost. 1995;73:402-404.
24. Vanderbroucke J, Koster T, Briët E, Reitsma P, Bertina R, Rosendaal F. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor v leiden mutation. Lancet. 1994;344:1453-1057.
25. Ossei Gerning N, Wilson IJ, Grant PJ. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Thromb Haemost. 1998;79:736-740.
26. Kiechl S, Willeit J, Egger G, Poewe W, F O. Body iron stores and the risk of carotid atherosclerosis: prospective results from the bruneck study. Circulation. 1997;96:3300-3307.
27. Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall EE. Risk factors for coronary heart disease: Implications of gender. Cardiovasc Res. 2002;53:538-549.
28. Jensen Urstad K, Johansson J. Gender difference in age-related changes in vascular function. J Intern Med. 2001;250:29-36.